Alkermes plc. Operating Lease Right-of-Use Assets
Alkermes plc. (ALKS) had Operating Lease Right-of-Use Assets of $76.11 million as of 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-07-28
- 2026-06-30: Operating Lease, Right-of-Use Asset $76.11M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $78.25M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $77.21M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $79.13M.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2026-06-30 | $76.11M 10-Q · filed 2026-07-28 | |
| 2026-03-31 | $78.25M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $77.21M 10-Q · filed 2026-07-28 | |
| 2025-09-30 | $79.13M 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $80.53M 10-Q · filed 2025-07-29 | |
| 2025-03-31 | $82.41M 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $84.25M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $86.08M 10-Q · filed 2024-10-24 | |
| 2024-06-30 | $87.89M 10-Q · filed 2024-07-24 | |
| 2024-03-31 | $89.68M 10-Q · filed 2024-05-01 | |
| 2023-12-31 | $91.46M 10-K · filed 2025-02-12 | |
| 2023-09-30 | $103.17M 10-Q · filed 2023-10-25 | |
| 2023-06-30 | $107.36M 10-Q · filed 2023-07-26 | |
| 2023-03-31 | $111.59M 10-Q · filed 2023-04-26 | |
| 2022-12-31 | $97.54M 10-K · filed 2024-02-21 | $115.86M 10-K · filed 2023-02-16 |
| 2022-09-30 | $106.98M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $111.12M 10-Q · filed 2022-07-27 | |
| 2022-03-31 | $115.32M 10-Q · filed 2022-04-27 | |
| 2021-12-31 | $115.63M 10-K · filed 2023-02-16 | |
| 2021-09-30 | $118.76M 10-Q · filed 2021-10-27 | |
| 2021-06-30 | $123.01M 10-Q · filed 2021-07-28 | |
| 2021-03-31 | $127.43M 10-Q · filed 2021-04-28 | |
| 2020-12-31 | $131.72M 10-K · filed 2022-02-16 | |
| 2020-09-30 | $106.68M 10-Q · filed 2020-10-29 | |
| 2020-06-30 | $111.34M 10-Q · filed 2020-07-29 | |
| 2020-03-31 | $114.55M 10-Q · filed 2020-04-29 | |
| 2019-12-31 | $12.38M 10-K · filed 2021-02-11 | |
| 2019-09-30 | $13.84M 10-Q · filed 2019-10-23 | |
| 2019-06-30 | $15.91M 10-Q · filed 2019-07-25 | |
| 2019-03-31 | $18.01M 10-Q · filed 2019-04-25 | |
| 2019-01-01 | $20.10M 10-K · filed 2020-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |